Impaired Glucose Tolerance and Insulin Resistance: Risk Factors, Management and Health Implications

Sandra Wagner (Editor)

Series: Endocrinology Research and Clinical Developments
BISAC: MED027000

Clear

$95.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Browse Wishlist
Browse Wishlist

Details

The prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide, and it is becoming a public health concern. In this book, the pathophysiological risk factors of progression from normoglycemia to prediabetes and the lifestyle modifications and pharmacological interventions for preventing or delaying the development of glucose intolerance is examined. Furthermore, the insulin signaling pathway regulates the cellular uptake of glucose and wholebody metabolic homeostasis in mammalians.

This book explores the improvement of estrogen signaling in preventing the comorbidities of insulin resistance. The next chapter focuses on nutritional management during the perioperative period, focusing on glucose metabolism and insulin sensitivity. There are three major problems for nutritional management during the perioperative period. These problems are addressed and suggestions are made on how to alleviate them. Finally, Cystic Fibrosis (CF) is the most common lethal inherited disorder in Caucasians, affecting 1 in 2,500 – 2,800 live births. The last chapter examines impaired glucose tolerance in cystic fibrosis.
(Imprint: Nova Biomedical)

Preface

Chapter 1
The Epidemiology and Management of Prediabetes: A Preventable Disease
(Masanori Shimodaira, Department of Internal Medicine, Iida Municipal Hospital, Nagano, Japan)

Chapter 2
Improvement of Estrogen Signaling Upregulates Defective Cellular Glucose Uptake and Prevents the Comorbidities of Insulin Resistance
(Zsuzsanna Suba, National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Budapest, Hungary)

Chapter 3
Nutritional Management during Perioperative Period: Focusing on Glucose Metabolism and Insulin Sensitivity
(Takeshi Yokoyama, and Kunio Suwa, Professor, Department of Dental Anesthesiology, Faculty of Dental Science, Kyushu University Higashi-ku, Fukuoka, Japan, and others)

Chapter 4
Impaired Glucose Tolerance in Cystic Fibrosis
(Peter G. Middleton, Odette J. Erskine, D. Jane Holmes-Walker, Centre Director, Respiratory & Sleep Physician, Endocrinologist, Adult CF Service, Westmead Hospital, Sydney, Australia)

Index

You have not viewed any product yet.